Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs
Conclusion Long-term nucleos(t)ide analog therapy does not guarantee against the HCC development and mortality in chronic hepatitis B-related cirrhotic patients. Careful HCC surveillance is necessary in patients with old age, statin use, low platelet count, and variceal bleeding history.
Source: Journal of the Formosan Medical Association - Category: Journals (General) Source Type: research
More News: Bleeding | Cancer & Oncology | Carcinoma | Child Development | Cholesterol | Chronic Kidney Disease | Cirrhosis | General Medicine | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver Cancer | Statin Therapy | Study | Urology & Nephrology | Viread